7-Amino-3-methyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 95.0%, 25g

N-Butylbenzenesulfonamide, 95.0%, 100g

Adamantane, min. 99%, for synthesis, 25 g, glass packaging

Ethyl (E)-3-(2-fluorophenyl)prop-2-enoate, 95%, 5g

2-Chloro-4,6-dimethoxy-pyrimidine, 99.00%, 1g

7-Methoxy-2,3-dihydro-1H-inden-1-amine hydrochloride, 95.0%, 250mg

3',4',5',6'-Tetrahydroxy-3H-spiro[isobenzofuran-1,9'-xanthen]-3-one, 85.0%, 10g

2-Oxo-2,3-dihydro-1H-pyrrolo[2,3-b]pyridine-5-carbonitrile, 95.0%, 10g

1-vinyl-1H-pyrazole-4-carboxylic acid, 95.0%, 10g

(Triethylsilyl) acetylene, 97%, 10g

(3R,4S)-tert-Butyl 3,4-dihydroxypyrrolidine-1-carboxylate, 97.0%, 100mg

1-(Pyridin-4-ylmethyl)-4-(4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzyl)piperazine, 98%, 1g

tert-butyl 4-(2-chloro-5-fluoropyrimidin-4-yl)piperazine-1-carboxylate, 1g